Feasibility and Acceptability of a New Tool Promoting a Healthy Lifestyle in Liver and Kid
This interventional clinical trial tests whether a doctor-delivered lifestyle counseling program, supported by two personalized digital tools, is feasible and helpful for improving healthy eating and physical activity in older adults (65 years or older) who previously received a liver or kidney transplant. All particip
| Condition(s) | Liver Transplant, Kidney Transplant |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This interventional clinical trial tests whether a doctor-delivered lifestyle counseling program, supported by two personalized digital tools, is feasible and helpful for improving healthy eating and physical activity in older adults (65 years or older) who previously received a liver or kidney transplant. All participants first receive medical counseling on healthy diet and physical activity. After 12 weeks, they begin using two smartphone apps ("Gamebus" and "Nutrida") designed to support behavior change at home. Each participant acts as their own comparison, and results after starting the apps are compared with their own results before using them. The main goal is to find out whether participants can safely use the apps and follow the program (for example: staying in the study, using th |
| Who can participate | Inclusion Criteria: * Age ≥ 60 years * Liver or kidney transplant received at least 6 months and no more than 25 years prior * BMI between 21 and 29.9 * Signed informed consent * Having a personal smartphone * Stable immunosuppressive therapy in the past 3 months Exclusion Criteria: * Significant weight change (\>5% of body weight) in the past 3 months * Combined liver-kidney transplant * Medical conditions requiring specific diets that may render adherence to the dietary recommendations of the trial unsafe (e.g., chronic kidney disease, inflammatory bowel disease, celiac disease, bariatric surgery, etc.) * General physical conditions deemed by the investigator to contraindicate safe participation in any of the trial activities (e.g., blindness, vertebral fractures, wheelchair dependence, |
| Ages | 60 Years |
| Sex | All |
| Lead sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Locations | Bologna, BO, Italy |
| Start date | 2025-08-18 |
| NCT ID | NCT07305012 |
| Official listing | https://clinicaltrials.gov/study/NCT07305012 |